Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2017 August;65(4) > Minerva Cardioangiologica 2017 August;65(4):420-6

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  MODELING OF CARDIAC ARRHYTHMIAS 

Minerva Cardioangiologica 2017 August;65(4):420-6

DOI: 10.23736/S0026-4725.17.04371-7

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

The role of myocardial fibrosis in determining the success rate of ablation for the treatment of atrial fibrillation

Subothini SELVENDRAN 1, Nikhil AGGARWAL 1, Justin LI 2, Gary TSE 3, 4, Vassilios S., VASSILIOU 1, 5

1 Royal Brompton Hospital, Imperial College, London, UK; 2 Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China; 3 Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China; 4 School of Health Sciences, University of Manchester, Manchester, UK; 5 Norwich Medical School, University of East Anglia, Norwich, UK


PDF


Atrial fibrillation is the most common sustained cardiac arrhythmia and with an aging population its prevalence will increase. In addition to appropriate anticoagulation to reduce the thromboembolic risk, there has been an increasing need for a personalized approach in identifying which patients are likely to benefit more from atrial fibrillation ablation procedures. This review will discuss the role of myocardial fibrosis in patients with atrial fibrillation, its mechanistic role, association with biomarkers and how this could potentially be of use in the development of a risk score identifying the success of maintaining sinus rhythm following an electrophysiological ablation.


KEY WORDS: Atrial fibrillation - Ablation techniques - Endomyocardial fibrosis

top of page